BREAKING🔔 A new study from G2P-Japan🇯🇵 is out! The preprint will be out so soon, but first we show our results on BA.2.86 - transmissibility, infectivity and immune resistance. This would be the 4th non-peer-reviewed🗒, but includes some new stuff. Please retweet/repost🔥 1/
Cf. Non-peer-reviewed works on BA.2.86:
The 1st🗒 from @yunlong_cao :
The 2nd🗒 from @BenjMurrell :
The 3rd🗒 from @BarouchLab :
Here I summarized the mutations detected in BA.2.86. 2/
1⃣Transmissibility/fitness (Re):
Analysis by Jumpei @jampei2 using the data from 🇩🇰 showed that BA.2.86's Re is greater than XBB.1.5 and comparable to or even greater than EG.5.1. 3/
2⃣Infectivity (pseudovirus):
BA.2.86 is ~20-fold LESS infectious than EG.5.1. 4/
3⃣Immune resistance:
All vaccine sera tested (monox3, monox4, BA.1 bivalent, and BA.5 bivalent) showed NO neutralizing activity against BA.2.86 (and EG.5.1). 5/
Three monoclonal antibodies (Bebtelovimab, Sotrovimab, Tixagevimab) that were antiviral against the parental BA.2 (see the G2P-Japan 9th paper) did NOT work against BA.2.86 AT ALL. 6/
Finally, the anti-BA.2.86 activity of XBB breakthrough infection sera was PRETTY POOR, and BA.2.86 was significantly (1.6-fold) more resistant to these sera than EG.5.1. 7/
Altogether, it is suggested that BA.2.86 is one of the most highly immune evasive variants ever and should have the potential to be considered as a variant of interest. 8/
Btw, 2 inturnship students from 🇮🇩 and 🇬🇧, Olivia and Yoonjin, did a great job in this urgent project. A great summer labwork🌊!! 9/
• • •
Missing some Tweet in this thread? You can try to
force a refresh
BREAKING🔔 A new preprint from G2P-Japan🇯🇵 is out at bioRxiv @biorxivpreprint. We evaluated the antiviral humoral immunity induced by breakthrough infection (BTI) of XBB subvariants and its effect against a new one, EG.5. Please RT. 1/ biorxiv.org/content/10.110…
Currently, a subvariant of XBB.1.9, EG.5 (aka XBB.1.9.2.5) is well documented in Twitter (maybe aka #X) and elsewhere.
EG.5.1 S = XBB.1.9.2 S + Q52H + F456L, and XBB.1.9.2 S = XBB.1.5 S. 2/
https://t.co/Tm6soayTIV
BREAKING🔔 The 23rd paper from G2P-Japan🇯🇵 is out at Journal of Infectious Diseases @JIDJournal. Using animal model, we assessed the impact of imprinted immunity induced by mRNA vaccine. The result is striking, but this thread should be read to the end🧵1/ academic.oup.com/jid/advance-ar…
First, in the case of unvaccinated animals, natural SARS-CoV-2 infection efficiently induced antiviral humoral immunity against the variant infected (B.1.1, BA.2, BQ.1 or XBB.1). 2/
Strikingly, however, in the case of animals vaccinated with 3 doses of mRNA vaccine, the sera of the hamsters with breakthrough XBB.1 infection showed very weak anti-XBB.1 activity (indicated with red arrow)!! 3/